skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines risankizumabQuestion & answer

risankizumab · Medicine question

What is the most frequently reported adverse reaction to risankizumab?

iatroX medicinesPublished 8 November 2026

The answer

Answer

Upper respiratory infections were the most frequently reported adverse reactions to risankizumab.

Sources for this answer

Skyrizi 150 mg solution for injection in pre-filled penAbbVie Ltd · emc · SmPC §4.8 Undesirable effects · Version 11Document updated 10 December 2025

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

More questions about risankizumab

Does risankizumab affect the ability to drive or use machines?For how long after stopping risankizumab is effective contraception recommended for women of childbearing potential?Has the safety and efficacy of risankizumab combined with other biologics or phototherapy been evaluated?How does risankizumab block interleukin-23 signalling?How much polysorbate 20 does each Skyrizi (risankizumab) 150 mg pre-filled pen contain?What tuberculosis screening is recommended before starting risankizumab?

risankizumab

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the risankizumab guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX